Physician profile
Kyle Clark Kimbal
NPI 1104205442
$21,564.31
in general payments reported to CMS, 2019-2025
21 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $6,023 · 2021: $6,763 · 2022: $2,637 · 2023: $2,935 · 2024: $1,422 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,338 · Travel and Lodging: $2,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,338.01 |
| Travel and Lodging | $2,429.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,533.89 | 2021-2025 | Valiant Captivia, Venaseal, Endurant Iis |
| W. L. Gore & Associates, INC. | $4,631.19 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis |
| Medtronic Vascular, INC. | $4,455.38 | 2019-2020 | |
| Penumbra, INC. | $2,039.97 | 2023-2024 | Indigo System, Penumbra System |
| Silk Road Medical, INC. | $1,158.60 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $1,085.84 | 2022-2024 | Alto Abdominal Stent Graft System |
| Cook Medical LLC | $944.12 | 2021-2022 | |
| Bolton Medical INC | $471.01 | 2021-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Terumo Medical Corporation | $236.04 | 2021-2022 | |
| Boston Scientific Corporation | $181.46 | 2025 | Enhance Transcarotid Peripheral Access Kit, Enroute Transcarotid Neuroprotection System, General - Vascular Intervention |
| Shockwave Medical, INC | $175.96 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Incorporated | $140.85 | 2020 | |
| Abbott Laboratories | $120.68 | 2021-2024 | Esprit |
| Bioventus LLC | $115.33 | 2023 | Sonicone Clinic |
| Kci USA, INC. | $59.26 | 2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $57.13 | 2022-2023 | Venclose Maven Catheter |
| Becton, Dickinson and Company | $51.67 | 2022-2023 | Rotarexs 6 F X 135 Cm |
| Lemaitre Vascular, INC. | $33.06 | 2024 | Anastoclip Gc 8cm (Medium), Hydro Lemaitre Valvulotome |
| Novartis Pharmaceuticals Corporation | $29.67 | 2024 | |
| Cardiovascular Systems INC. | $22.31 | 2021 | |
| Asahi Intecc USA, INC. | $20.89 | 2023 | Asahi Ptca Guide Wire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kimbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.